These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


326 related items for PubMed ID: 7684421

  • 1. EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2.
    Khanna R, Burrows SR, Suhrbier A, Jacob CA, Griffin H, Misko IS, Sculley TB, Rowe M, Rickinson AB, Moss DJ.
    J Immunol; 1993 Jun 01; 150(11):5154-62. PubMed ID: 7684421
    [Abstract] [Full Text] [Related]

  • 2. Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance.
    Gregory CD, Murray RJ, Edwards CF, Rickinson AB.
    J Exp Med; 1988 Jun 01; 167(6):1811-24. PubMed ID: 2898508
    [Abstract] [Full Text] [Related]

  • 3. Restoration of the LFA-3 adhesion pathway in Burkitt's lymphoma cells using an LFA-3 recombinant vaccinia virus: consequences for T cell recognition.
    Griffin H, Rowe M, Murray R, Brooks J, Rickinson A.
    Eur J Immunol; 1992 Jul 01; 22(7):1741-8. PubMed ID: 1378014
    [Abstract] [Full Text] [Related]

  • 4. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG, Zhang QJ, Gavioli R, De Campos-Lima PO, Murray RJ, Brooks J, Griffin H, Ploegh H, Rickinson AB.
    Int Immunol; 1992 Nov 01; 4(11):1283-92. PubMed ID: 1282031
    [Abstract] [Full Text] [Related]

  • 5. T cell recognition of Epstein-Barr virus associated lymphomas.
    Rickinson AB, Murray RJ, Brooks J, Griffin H, Moss DJ, Masucci MG.
    Cancer Surv; 1992 Nov 01; 13():53-80. PubMed ID: 1330300
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CD2/LFA-3 or LFA-1/ICAM-1 but not CD28/B7 interactions can augment cytotoxicity by virus-specific CD8+ cytotoxic T lymphocytes.
    de Waal Malefyt R, Verma S, Bejarano MT, Ranes-Goldberg M, Hill M, Spits H.
    Eur J Immunol; 1993 Feb 01; 23(2):418-24. PubMed ID: 7679643
    [Abstract] [Full Text] [Related]

  • 8. Class I processing-defective Burkitt's lymphoma cells are recognized efficiently by CD4+ EBV-specific CTLs.
    Khanna R, Burrows SR, Thomson SA, Moss DJ, Cresswell P, Poulsen LM, Cooper L.
    J Immunol; 1997 Apr 15; 158(8):3619-25. PubMed ID: 9103423
    [Abstract] [Full Text] [Related]

  • 9. Low expression of lymphocyte function-associated antigen (LFA)-1 and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and not associated with Epstein-Barr virus.
    Billaud M, Rousset F, Calender A, Cordier M, Aubry JP, Laisse V, Lenoir GM.
    Blood; 1990 May 01; 75(9):1827-33. PubMed ID: 1691936
    [Abstract] [Full Text] [Related]

  • 10. Clonal heterogeneity in LFA-3 and ICAM-1 requirement for lysis by alloreactive T lymphocytes.
    Galocha B, López D, López de Castro JA.
    J Immunol; 1993 Mar 01; 150(5):1653-62. PubMed ID: 7679690
    [Abstract] [Full Text] [Related]

  • 11. Cross-recognition of a mouse H-2-peptide complex by human HLA-restricted cytotoxic T cells.
    Murray RJ, Brooks JM, Rickinson AB, Rowe M.
    Eur J Immunol; 1990 Mar 01; 20(3):659-64. PubMed ID: 1690661
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lysis of human keratinocytes by allogeneic HLA class I-specific cytotoxic T cells. Keratinocyte ICAM-1 (CD54) and T cell LFA-1 (CD11a/CD18) mediate enhanced lysis of IFN-gamma-treated keratinocytes.
    Symington FW, Santos EB.
    J Immunol; 1991 Apr 01; 146(7):2169-75. PubMed ID: 1672345
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus isolates with the major HLA B35.01-restricted cytotoxic T lymphocyte epitope are prevalent in a highly B35.01-positive African population.
    Lee SP, Morgan S, Skinner J, Thomas WA, Jones SR, Sutton J, Khanna R, Whittle HC, Rickinson AB.
    Eur J Immunol; 1995 Jan 01; 25(1):102-10. PubMed ID: 7531142
    [Abstract] [Full Text] [Related]

  • 16. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.
    Okugawa K, Itoh T, Kawashima I, Takesako K, Mazda O, Nukaya I, Yano Y, Yamamoto Y, Yamagishi H, Ueda Y.
    Oncol Rep; 2004 Oct 01; 12(4):725-31. PubMed ID: 15375491
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of the adhesion molecule ICAM-1 (CD54) in staphylococcal enterotoxin-mediated cytotoxicity.
    Dohlsten M, Hedlund G, Lando PA, Trowsdale J, Altmann D, Patarroyo M, Fischer H, Kalland T.
    Eur J Immunol; 1991 Jan 01; 21(1):131-5. PubMed ID: 1671356
    [Abstract] [Full Text] [Related]

  • 19. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
    Hill AB, Lee SP, Haurum JS, Murray N, Yao QY, Rowe M, Signoret N, Rickinson AB, McMichael AJ.
    J Exp Med; 1995 Jun 01; 181(6):2221-8. PubMed ID: 7539044
    [Abstract] [Full Text] [Related]

  • 20. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
    Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ.
    J Exp Med; 1992 Jul 01; 176(1):169-76. PubMed ID: 1377222
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.